REDHILL BIOPHARMA LTD. (RDHL) Operating margin 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) operating margin by fiscal year — reported operating income divided by reported revenue.
-181.7%FY2024 · since FY2015: -733400.0% → -181.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -181.7% | -375.1 pp |
| FY2023 | 193.4% | +262.8 pp |
| FY2022 | -69.3% | +25.3 pp |
| FY2021 | -94.6% | +4.3 pp |
| FY2020 | -99.0% | +587.8 pp |
| FY2019 | -686.7% | -216.2 pp |
| FY2018 | -470.5% | +826.6 pp |
| FY2017 | -1297.0% | +28943.6 pp |
| FY2016 | -30240.6% | +703159.4 pp |
| FY2015 | -733400.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RDHL financial trends
RDHL RevenueRDHL Net incomeRDHL Net marginRDHL Gross profitRDHL Gross marginRDHL Operating incomeRDHL Operating cash flowRDHL Free cash flowRDHL Capital expendituresRDHL Return on equityRDHL Stock buybacksRDHL Dividends paidRDHL Total assetsRDHL Total liabilitiesRDHL Shareholders’ equityRDHL overview →